LAVA Therapeutics shareholders approve all proposals at 2025 annual meeting

LAVA Therapeutics NV

Annual meeting held June 11, 2025; 16,335,339 shares (62.1% of outstanding) represented.
Adopted Dutch statutory annual accounts for 2024: 61.3M votes for, 2,066 against.
Appointed KPMG Accountants N.V. as external auditor for 2025: 16.3M for.
Ratified KPMG LLP as independent auditor for 2025: 16.3M for.
Reappointed directors Jay Backstrom and James Noble as non-executive directors.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.